Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Na?ve Cirrhotic Patients Infected with HCV Genotype 4

导出原文传递

翻译打印收藏纠错

作者： Sayed Ahmed ^[1] ; Essam Hassan ^[2] ; Ahmed Gomaa ^[3] ; Gamal Esamat ^[4] ; Ahmed Ramadan ^[5] ; Manar Ahmed ; Aya Elsayed ; Engy A. Wahsh

作者单位： Fayoum University,Department of Tropical Medicine, Faculty of Medicine,Fayoum,Egypt,63511, ^[1] Cairo Universit,Department of Endemic Medicine, Faculty of Medicine,Cairo,Egypt, ^[2] Cairo University,Department of Endemic Medicine, Faculty of Medicine,Cairo,Egypt, ^[3] Beni Suef University,Department of Clinical Pharmacy, Faculty of Pharmacy,Beni Suef,Egypt,62521, ^[4] October 6 University,Department of Clinical Pharmacy, Faculty of Pharmacy,Giza,Egypt,12573, ^[5]

关键词 Hepatitis C virus sofosbuvir daclatasvir simeprevir ribavirin genotype-4.

发布时间 2023-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交